ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 992,87
0,18%
Dow Jones
38 686,32
1,51%
DAX
18 497,94
-0,09%
Brent Oil
81,295
0,00%
Bitcoin
67 741,24
0,38%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Neuroderm Ltd. - Ordinary Shares (NDRM)

  7. Neuroderm Ltd. - Ordinary Shares (NDRM) Actualités

NDRM

NEURODERM LTD. (NDRM)

Neuroderm Ltd. - Ordinary Shares
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:NDRM
DateHeureSourceTitreSymboleSociété
30/10/201711h10Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:NDRMNeuroderm Ltd. - Ordinary Shares
23/10/201712h02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:NDRMNeuroderm Ltd. - Ordinary Shares
18/10/201714h17Edgar (US Regulatory)(25-NSE)NASDAQ:NDRMNeuroderm Ltd. - Ordinary Shares
18/10/201712h25Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:NDRMNeuroderm Ltd. - Ordinary Shares
18/10/201712h16Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:NDRMNeuroderm Ltd. - Ordinary Shares
18/10/201712h12Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:NDRMNeuroderm Ltd. - Ordinary Shares
18/10/201710h23GlobeNewswire Inc.Mitsubishi Tanabe Pharma Corporation Completes Acquisition of NeuroDermNASDAQ:NDRMNeuroderm Ltd. - Ordinary Shares
12/09/201714h37GlobeNewswire Inc.NeuroDerm Shareholders Approve Proposed Acquisition by Mitsubishi Tanabe Pharma CorporationNASDAQ:NDRMNeuroderm Ltd. - Ordinary Shares
11/09/201722h07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:NDRMNeuroderm Ltd. - Ordinary Shares
03/08/201722h05GlobeNewswire Inc.NeuroDerm Announces Second Quarter 2017 Financial ResultsNASDAQ:NDRMNeuroderm Ltd. - Ordinary Shares
01/08/201722h05GlobeNewswire Inc.NeuroDerm Announces Extraordinary General Meeting of Shareholders to Approve Acquisition by Mitsubishi Tanabe Pharma Corporat...NASDAQ:NDRMNeuroderm Ltd. - Ordinary Shares
24/07/201708h00GlobeNewswire Inc.NeuroDerm Enters Definitive Agreement to be Acquired by Mitsubishi Tanabe Pharma Corporation for US$1.1 Billion in CashNASDAQ:NDRMNeuroderm Ltd. - Ordinary Shares
27/06/201713h00GlobeNewswire Inc.Results of NeuroDerm’s ND0612H Phase II Trial Presented in Oral Session at the 3rd Congress of the European Academy of Neur...NASDAQ:NDRMNeuroderm Ltd. - Ordinary Shares
08/06/201718h01GlobeNewswire Inc.NeuroDerm Presents Six Posters at the 21st International Congress of Parkinson’s Disease and Movement DisordersNASDAQ:NDRMNeuroderm Ltd. - Ordinary Shares
06/06/201715h06GlobeNewswire Inc.European Medicines Agency Accepts Design of NeuroDerm’s ND0612 Phase III iNDiGO Efficacy TrialNASDAQ:NDRMNeuroderm Ltd. - Ordinary Shares
05/06/201718h01GlobeNewswire Inc.NeuroDerm Presents ND0612H Phase II Trial Results in Late-Breaking Poster Session at the 21st International Congress of Parki...NASDAQ:NDRMNeuroderm Ltd. - Ordinary Shares
30/05/201713h00GlobeNewswire Inc.NeuroDerm CEO to Present at the Jefferies Global Healthcare Conference on June 7, 2017NASDAQ:NDRMNeuroderm Ltd. - Ordinary Shares
23/05/201713h00GlobeNewswire Inc.NeuroDerm ND0612H Phase II Trial Results to be Presented in Late-Breaking Session at the 21st International Congress of Parki...NASDAQ:NDRMNeuroderm Ltd. - Ordinary Shares
11/05/201713h00GlobeNewswire Inc.NeuroDerm Announces First Quarter 2017 Financial ResultsNASDAQ:NDRMNeuroderm Ltd. - Ordinary Shares
20/04/201717h02GlobeNewswire Inc.NeuroDerm Ltd. (Nasdaq: NDRM) to Ring The Nasdaq Stock Market Opening BellNASDAQ:NDRMNeuroderm Ltd. - Ordinary Shares
20/04/201717h00GlobeNewswire Inc.NeuroDerm to Ring the Nasdaq Stock Market Opening Bell and Participate in the Parkinson’s Unity WalkNASDAQ:NDRMNeuroderm Ltd. - Ordinary Shares
10/04/201713h00GlobeNewswire Inc.NeuroDerm to Host Investor Day on April 21, 2017NASDAQ:NDRMNeuroderm Ltd. - Ordinary Shares
03/04/201718h53Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:NDRMNeuroderm Ltd. - Ordinary Shares
30/03/201713h00GlobeNewswire Inc.NeuroDerm Announces Fourth Quarter and Full Year 2016 Financial ResultsNASDAQ:NDRMNeuroderm Ltd. - Ordinary Shares
29/03/201723h23Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:NDRMNeuroderm Ltd. - Ordinary Shares
21/03/201712h00GlobeNewswire Inc.NeuroDerm to Host Fourth Quarter and 2016 Fiscal Year Financial Results Conference Call on March 30, 2017NASDAQ:NDRMNeuroderm Ltd. - Ordinary Shares
01/03/201713h00GlobeNewswire Inc.NeuroDerm Achieves Primary Endpoint in ND0612H Phase II Trial for Advanced Parkinson’s Disease; Seeks Broader EU Label Base...NASDAQ:NDRMNeuroderm Ltd. - Ordinary Shares
27/02/201722h01GlobeNewswire Inc.NeuroDerm CEO to Present at Upcoming Investor ConferencesNASDAQ:NDRMNeuroderm Ltd. - Ordinary Shares
26/01/201722h01GlobeNewswire Inc.NeuroDerm Announces Extraordinary General Meeting of ShareholdersNASDAQ:NDRMNeuroderm Ltd. - Ordinary Shares
03/01/201713h00GlobeNewswire Inc.NeuroDerm CEO to Present at the 35th Annual J.P. Morgan Healthcare Conference on January 12, 2017NASDAQ:NDRMNeuroderm Ltd. - Ordinary Shares
 Showing the most relevant articles for your search:NASDAQ:NDRM

Dernières Valeurs Consultées

BIT
UC4J4H
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés